Broadcast Date: 
  • Time: 

Lack of cellular differentiation is a hallmark of many human cancers, including acute myeloid leukemia (AML). Strategies to overcome such differentiation blockade, a notion known as “differentiation therapy,” represent an alternative approach for treating a subset of AML patients, a disease marked by a dismal prognosis and limited therapeutic options.

In this GEN webinar, Dr. Eric Wang from Memorial Sloan Kettering Cancer Center will speak about his recent work on using CRISPR technologies, including single-cell multimodal CRISPR screening (also known as ECCITE-seq), to discover new regulators of leukemia differentiation and potential therapeutic targets for differentiation-based therapies in AML.


A live Q&A session followed the presentation, offering a chance to pose questions to our expert panelists.



Webinar produced with support from:

10x Genomics logo
Eric Wang, PhD
Eric Wang, PhD
Postdoctoral Fellow
Memorial Sloan Kettering Cancer Center